Sep 03, 2024
|
Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference
|
Aug 30, 2024
|
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
Aug 13, 2024
|
Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update
|
Aug 06, 2024
|
Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024
|
Jul 05, 2024
|
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
May 30, 2024
|
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
|
May 01, 2024
|
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
|
Apr 24, 2024
|
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
|
Apr 16, 2024
|
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Mar 21, 2024
|
Chimerix Appoints Marc D. Kozin to Board of Directors
|